Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. Epub 2022 Jan 12. PMID: 35020204.

Article  PubMed  Google Scholar 

Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225–34. https://doi.org/10.1016/S2213-8587(21)00027-9. Epub 2021 Mar 1. PMID: 33662333.

Article  PubMed  Google Scholar 

Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418–28. https://doi.org/10.1016/0002-9343(94)90321-2. Erratum in: Am J Med 1995;98(2):215. PMID: 7977430.

Article  CAS  PubMed  Google Scholar 

Eustatia-Rutten CF, Corssmit EP, Biermasz NR, et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2006;91(1):313–9. https://doi.org/10.1210/jc.2005-1322. Epub 2005 Nov 1. PMID: 16263822.

Article  CAS  PubMed  Google Scholar 

Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104(6):947–53. PMID: 3194846.

Article  CAS  PubMed  Google Scholar 

Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102(6):1088–95. PMID: 3686348.

CAS  PubMed  Google Scholar 

Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050–7. discussion 1057-8. PMID: 8256208.

CAS  PubMed  Google Scholar 

Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1):79–84. https://doi.org/10.1007/s10875-012-9847-0. Epub 2012 Dec 9. PMID: 23225204.

Article  CAS  Google Scholar 

Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19–26;420(6917):860-7. https://doi.org/10.1038/nature01322. PMID: 12490959; PMCID: PMC2803035.

de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24–37. https://doi.org/10.1038/nrc1782. PMID: 16397525.

Article  CAS  PubMed  Google Scholar 

Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014;6(3):1670–90. https://doi.org/10.3390/cancers6031670. PMID: 25125485; PMCID: PMC4190561.

Article  PubMed  Google Scholar 

Dupré A, Malik HZ. Inflammation and cancer: what a surgical oncologist should know. Eur J Surg Oncol. 2018;44(5):566–70. https://doi.org/10.1016/j.ejso.2018.02.209. Epub 2018 Mar 2. PMID: 29530345.

Article  PubMed  Google Scholar 

Ozmen S, Timur O, Calik I, Altinkaynak K, Simsek E, Gozcu H, Arslan A, Carlioglu A. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer. Endocr Regul. 2017;51(3):131–136. https://doi.org/10.1515/enr-2017-0013. PMID: 28858848.

Kim JY, Park T, Jeong SH, et al. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine. 2014;46(3):526–31. https://doi.org/10.1007/s12020-013-0089-6. Epub 2013 Nov 23. PMID: 24272600.

Article  CAS  PubMed  Google Scholar 

Gong W, Yang S, Yang X, et al. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer. Clin (Sao Paulo). 2016;71(6):311–4. https://doi.org/10.6061/clinics/2016(06)04. PMID: 27438563; PMCID: PMC4930667.

Article  Google Scholar 

Liu CL, Lee JJ, Liu TP, et al. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol. 2013;107(5):493–7. https://doi.org/10.1002/jso.23270. Epub 2012 Sep 20. PMID: 22996403.

Article  PubMed  Google Scholar 

Yokota M, Katoh H, Nishimiya H, et al. Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid Cancer. J Surg Res. 2020;246:535–43. https://doi.org/10.1016/j.jss.2019.09.034. Epub 2019 Nov 9. PMID: 31711613.

Article  CAS  PubMed  Google Scholar 

Kim K, Pak K, Kim IJ, et al. Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer. Endocrine. 2020;70(2):364–71. https://doi.org/10.1007/s12020-020-02328-y. Epub 2020 May 5. PMID: 32372305.

Article  CAS  PubMed  Google Scholar 

Song L, Zhu J, Li Z, et al. The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma. Cancer Manag Res. 2019;11:8451–62. https://doi.org/10.2147/CMAR.S219163. PMID: 31572000; PMCID: PMC6756579.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang K, Lei J, Chen W, et al. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma. Med (Baltim). 2016;95(40):e5079. https://doi.org/10.1097/MD.0000000000005079. PMID: 27749581; PMCID: PMC5059084.

Article  CAS  Google Scholar 

Jiang K, Lei J, Li C, et al. Comparison of the prognostic values of selected inflammation based scores in patients with medullary thyroid carcinoma: a pilot study. J Surg Oncol. 2017;116(3):281–7. https://doi.org/10.1002/jso.24683. Epub 2017 May 29. PMID: 28556902.

Article  CAS  PubMed  Google Scholar 

Kim SM, Kim EH, Kim BH, et al. Association of the preoperative neutrophil-to-ymphocyte count ratio and platelet-to-lymphocyte count ratio with clinicopathological characteristics in patients with papillary thyroid Cancer. Endocrinol Metab (Seoul). 2015;30(4):494–501. Epub 2015 Sep 10. PMID: 26354491; PMCID: PMC4722404.

Article  CAS  PubMed  Google Scholar 

Huang Y, Liu Y, Mo G et al. Inflammation markers have important value in Predicting Relapse in patients with papillary thyroid carcinoma: a long-term Follow-Up Retrospective Study. Cancer Control 2022 Jan-Dec;29:10732748221115236. https://doi.org/10.1177/10732748221115236. PMID: 35833862; PMCID: PMC9290143.

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100

Article  PubMed  PubMed Central  Google Scholar 

Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–6.

Article  PubMed  Google Scholar 

Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https://doi.org/10.1186/1745-6215-8-16. PMID: 17555582; PMCID: PMC1920534.

Article  PubMed  PubMed Central  Google Scholar 

Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–29.

Article  Google Scholar 

Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31(29):3805-20. doi: 10.1002/sim.5453. Epub 2012 Jul 4. PMID: 22763950; PMCID: PMC3546377.

Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112–25. https://doi.org/10.1002/jrsm.11. Epub 2010 Oct 4. PMID: 26061377.

Article  PubMed  Google Scholar 

Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34. https://doi.org/10.1136/bmj.315.7109.629. PMID: 9310563; PMCID: PMC2127453.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455 – 63. https://doi.org/10.1111/j.0006-341x.2000.00455.x. PMID: 10877304.

Chen W, Wei T, Li Z, et al. Association of the preoperative inflammation-based scores with TNM Stage and recurrence in patients with papillary thyroid carcinoma: a Retrospective, Multicenter Analysis. Cancer Manag Res. 2020;12:1809–18. PMID: 32210623; PMCID: PMC7073431.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lang BH, Ng CP, Au KB et al. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma? World J Surg. 2014;38(10):2605-12. https://doi.org/10.1007/s00268-014-2630-z. PMID: 24809487.

Lee KH, Seok EY, Kim EY, et al. Different prognostic values of individual hematologic parameters in papillary thyroid cancer due to age-related changes in immunity. Ann Surg Treat Res. 2019;96(2):70–7. https://doi.org/10.4174/astr.2019.96.2.70. Epub 2018 Jan 30. PMID: 30746354; PMCID: PMC6358596.

Article  CAS  PubMed  Google Scholar 

Offi C, Romano RM, Cangiano A, et al. Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital. 2021;41(1):31–8. https://doi.org/10.14639/0392-100X-N1089. PMID: 33746220; PMCID: PMC7982751.

Article  PubMed  PubMed Central  Google Scholar 

Riguetto CM, Barreto IS, Maia FFR, et al. Usefulness of pre-thyroidectomy neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer. Clin (Sao Paulo). 2021;76:e3022. https://doi.org/10.6061/clinics/2021/e3022. PMID: 34406270; PMCID: PMC8341041.

Article  Google Scholar 

Zhang L, Luo H, Wang L, et al. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer. J Surg Oncol. 2020;122(5):897–905. https://doi.org/10.1002/jso.26089. Epub 2020 Jun 28. PMID: 32596828.

Article  CAS  PubMed  Google Scholar 

Zhou C, Duan D, Liu S. Predictive value of a Prognostic Model based on lymphocyte-to-monocyte ratio before Radioiodine Therapy for recurrence of papillary thyroid carcinoma. Technol Cancer Res Treat 2021 Jan-Dec 20:15330338211027910. https://doi.org/10.1177/15330338211027910. PMID: 34191658; PMCID: PMC8252333.

Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132.

Article  PubMed  PubMed Central  Google Scholar 

Szczerba BM, Castro-Giner F, Vetter M, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566(7745):553–7. https://doi.org/10.1038/s41586-019-0915-y. Epub 2019 Feb 6. PMID: 30728496.

Article  CAS  PubMed